At JPA Health, we collaborate with clients to elevate scientific communication for both patients and HCPs, contributing to advancements in medicine and better health outcomes.

In May 2024, JPA acquired BioCentric, Inc, an award-winning medical communications agency >

Together, our expertise spans the entire product lifecycle, crafting client-focused engagements that powerfully support the drug development and commercialization journey—from the bench to the clinic, from physicians to patients.

Our team of professionals excel in handling complex data, transforming it into visually compelling presentations that meet our clients’ communication objectives.

With a global perspective and deep understanding of both the U.S. and European markets, we ensure our solutions are innovative, strategically driven, and clinically pertinent. Our expanded services include medical affairs strategy, publication planning, scientific communications and running KOL advisory boards. Additionally, BioCentric brings with it a best-in-class learning and training team, along with expertise in applying modern game mechanics and interactive media to research, education, and behavior change applications.